\nNuveen Floating Rate Income Fund (NYSE: JFR) today announced that its Board of Trustees (the \u201cBoard\u201d) has approved the terms of the issuance of transferable rights (\u201cRights\u201d) to the holders of the Fund\u2019s common shares (par value $.01 per share) (\u201cCommon Shares\u201d) as of January 21, 2025 (the \u201cRecord Date\u201d). Holders of Rights will be entitled to subscribe for additional Common Shares (the \u201cOffer\u201d) at a discount to the market price of the Common Shares.<\/p>\n
\nAfter considering a number of factors, including potential benefits and costs, the Board and the Fund\u2019s investment adviser, Nuveen Fund Advisors, LLC (the \u201cAdviser\u201d), have determined that the Offer will benefit both the Fund and its shareholders and increase the assets of the Fund available to take advantage of existing investment opportunities, consistent with the Fund\u2019s investment objective of providing shareholders with a high level of current income.<\/p>\n
\nThe Adviser believes this is an attractive time to raise additional assets for the Fund based on several factors, including the following potential benefits:<\/p>\n
- \n
- Opportunities in senior loans:<\/b> investments in performing loans priced below par offer attractive current valuations and the potential to enhance portfolio yields and fund earnings while improving the potential for investment performance for all shareholders\n<\/li>\n
- Tax-efficiency:<\/b> potential to invest in new opportunities without the need to sell existing portfolio positions, which may reduce taxable events for shareholders\n<\/li>\n
- Benefit for shareholders:<\/b> the Offer provides shareholders with an opportunity to buy new Common Shares below market price\n<\/li>\n
- Enhanced liquidity:<\/b> the Offer creates the potential for increased trading volume and liquidity of Common Shares\n<\/li>\n
- Lower expense ratio:<\/b> the Offer is expected to spread fixed operating costs across a larger asset base\n<\/li>\n<\/ul>\n
\nCertain key terms of the Offer include:<\/p>\n
- \n
- \nHolders of Common Shares on the Record Date (\u201cRecord Date Shareholders\u201d) will receive one Right for each outstanding Common Share owned on the Record Date. The Rights entitle the holders to purchase one new Common Share for every 5 Rights held (1-for-5).<\/p>\n<\/li>\n
- \nThe subscription price per Common Share (the \u201cSubscription Price\u201d) will be determined based upon a formula equal to 95% of the average of the last reported sales price of the Common Shares on the NYSE on the Expiration Date and each of the four (4) preceding trading days (the \u201cFormula Price\u201d). If, however, the Formula Price is less than 90% of the net asset value per Common Share at the close of trading on the NYSE on the Expiration Date, then the Subscription Price will be 90% of the Fund\u2019s net asset value per Common Share at the close of trading on the NYSE on the Expiration Date. The Rights offering will expire at 5:00 p.m., Eastern time, on February 19, 2025 (the \u201cExpiration Date\u201d).<\/p>\n<\/li>\n
- \nRecord Date Shareholders who fully exercise all Rights issued to them can subscribe, subject to certain limitations and allotment, for any additional Common Shares which were not subscribed for by other holders of Rights at the Subscription Price, subject to the right of the Board to eliminate this over-subscription privilege. Investors who are not Record Date Shareholders but who otherwise acquire Rights in the secondary market are not entitled to participate in the over-subscription privilege.<\/b> If these requests exceed available Common Shares, they will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund.<\/p>\n<\/li>\n
- \nRights are transferable and are expected to be admitted for trading on the NYSE under the symbol \u201cJFR RTWI\u201d initially trading \u201cwhen-issued\u201d on January 17, 2025. The Rights will begin trading with regular settlement under the symbol \u201cJFR RT\u201d on or about January 23, 2025, and will cease trading at the close on February 18, 2025, one day before the Offer\u2019s Expiration Date. During this time, Record Date Shareholders may also choose to sell their Rights.<\/p>\n<\/li>\n<\/ul>\n
\nThe Fund has declared monthly distributions payable on February 3, 2025 and March 3, 2025, with record dates of January 15, 2025 and February 14, 2025, respectively. Any Common Shares issued after such record dates as a result of the Rights offering will not be record date Common Shares for the Fund\u2019s monthly distributions to be paid on February 3, 2025 and March 3, 2025 and will not be entitled to receive such distributions.<\/b><\/p>\n
\nThe Offer will be made only by means of a prospectus supplement and accompanying prospectus. The final terms of the Offer may be different from those set out above and the terms included in the prospectus supplement and accompanying prospectus will control.<\/p>\n
The information in this press release is not complete and is subject to change. This document is not an offer to sell any securities and is not soliciting an offer to buy any securities in any jurisdiction where the offer or sale is not permitted. This document is not an offering, which can only be made by a prospectus. Investors should consider the Fund\u2019s investment objective, risks, charges and expenses carefully before investing. The Fund\u2019s prospectus supplement and accompanying prospectus will contain this and additional information about the Fund and additional information about the Offer, and should be read carefully before investing. For further information regarding the Offer, or to obtain a prospectus supplement and the accompanying prospectus, when available, please contact the Fund\u2019s information agent:<\/b><\/p>\n
\nGeorgeson LLC:
\n
833-880-3673<\/p>\n\nFor more information, please visit Nuveen\u2019s CEF homepage www.nuveen.com\/closed-end-funds<\/a> or contact:<\/p>\n
\nFinancial Professionals:
\n
800-752-8700<\/p>\n\nInvestors:
\n
800-257-8787<\/p>\n\nMedia:
\n
media-inquiries@nuveen.com<\/a><\/p>\nAbout Nuveen<\/b><\/p>\n
\nNuveen, the investment manager of TIAA, offers a comprehensive range of outcome-focused investment solutions designed to secure the long-term financial goals of institutional and individual investors. Nuveen has $1.3 trillion in assets under management as of 30 Sept 2024 and operations in 27 countries. Its investment specialists offer deep expertise across a comprehensive range of traditional and alternative investments through a wide array of vehicles and customized strategies. For more information, please visit www.nuveen.com<\/a>.<\/p>\n
\nNuveen Securities, LLC, member FINRA and SIPC.<\/p>\n
\nThe information contained on the Nuveen website is not a part of this press release.<\/p>\n
\nCertain statements made in this release are forward-looking statements. Actual future results or occurrences may differ significantly from those anticipated in any forward-looking statements due to numerous factors. These include, but are not limited to:<\/p>\n
- \n
- \nmarket developments;<\/p>\n<\/li>\n
- \nlegal and regulatory developments; and<\/p>\n<\/li>\n
- \nother additional risks and uncertainties.<\/p>\n<\/li>\n<\/ul>\n
\nYou should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Nuveen and the closed-end funds managed by Nuveen and its affiliates undertake no responsibility to update publicly or revise any forward-looking statements.<\/p>\n
\nThe annual and semi-annual reports and other regulatory filings of Nuveen closed-end funds with the Securities and Exchange Commission (\u201cSEC\u201d) are accessible on the SEC\u2019s web site at www.sec.gov<\/a> and on Nuveen\u2019s website at www.nuveen.com\/cef<\/a> and may discuss the above-mentioned or other factors that affect Nuveen closed-end funds.<\/p>\n
\n4140394-0128<\/p>\n
<\/p>\n
View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250108456349\/en\/<\/a><\/span><\/p>\n
\nFinancial Professionals:
\n
800-752-8700<\/p>\n\nInvestors:
\n
800-257-8787<\/p>\n
- \nRights are transferable and are expected to be admitted for trading on the NYSE under the symbol \u201cJFR RTWI\u201d initially trading \u201cwhen-issued\u201d on January 17, 2025. The Rights will begin trading with regular settlement under the symbol \u201cJFR RT\u201d on or about January 23, 2025, and will cease trading at the close on February 18, 2025, one day before the Offer\u2019s Expiration Date. During this time, Record Date Shareholders may also choose to sell their Rights.<\/p>\n<\/li>\n<\/ul>\n
- Tax-efficiency:<\/b> potential to invest in new opportunities without the need to sell existing portfolio positions, which may reduce taxable events for shareholders\n<\/li>\n